NCT00440375View on ClinicalTrials.gov

Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women

PHASE4CompletedINTERVENTIONAL

Enrollment

82

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

March 31, 2006

Conditions

Type 2 Diabetes MellitusObesityMenopause

Interventions

DRUG

Rosiglitazone

All Listed Sponsors

lead

Baskent University

OTHER

NCT00440375 - Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women | Biotech Hunter | Biotech Hunter